Key result
Congenital myopathy gene panel identifies a pathogenic ACTA1 variant to enable early nemaline myopathy diagnosis.
Why the study?
Nemaline myopathy causes hypotonia, respiratory distress, and dysphagia in severe neonatal cases, prompting this report of a neonate diagnosed early via genetic testing.
Case Report (n=1)
No
Congenital myopathy genetic testing is a minimally invasive and highly useful tool for the early diagnosis of nemaline myopathy in neonates with unexplained hypotonia.
Answers are grounded in this paper and cite their sources.
May support early genetic diagnosis in hypotonic neonates; leaves open prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yoshikawa et al. (2026) conducted a case report in Nemaline myopathy (n=1). Congenital myopathy gene panel test was evaluated on Identification of pathogenic variant. A congenital myopathy gene panel test identified a pathogenic variant in the ACTA1 gene in a female infant with neonatal hypotonia, enabling early diagnosis of nemaline myopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: